NSE - Delayed Quote INR

Glenmark Pharmaceuticals Limited (GLENMARK.NS)

Compare
1,356.80
-20.10
(-1.46%)
At close: 3:30:00 PM GMT+5:30

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 33.88B
Earnings 3.48B

Q1'24

Q2'24

Q3'24

Q4'24

-10B
0
10B
20B
30B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

1,265.00
1,685.85 Average
1,356.80 Current
2,032.00 High

Earnings Estimate

Currency in INR Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1--1113
Avg. Estimate 12.1049.2162.14
Low Estimate 12.1044.658
High Estimate 12.105166.62
Year Ago EPS -28.212.06-35.3749.21

Revenue Estimate

Currency in INR Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 4--911
Avg. Estimate 33.17B--134.53B150.86B
Low Estimate 33.02B--133.75B145.78B
High Estimate 33.28B--135.44B154.51B
Year Ago Sales 30.63B--118.13B134.53B
Sales Growth (year/est) 8.31%--13.88%12.13%

Earnings History

Currency in INR 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. 5.511.314.713.9
EPS Actual -28.212.0612.5520.73
Difference -33.70.76-2.156.83
Surprise % -612.76%6.73%-14.63%49.13%

EPS Trend

Currency in INR Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 12.1049.2162.14
7 Days Ago 0049.6762.24
30 Days Ago 0049.862.26
60 Days Ago 0051.1563.08
90 Days Ago 0051.1363.06

EPS Revisions

Currency in INR Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days ------1
Down Last 7 Days ----12
Down Last 30 Days ----22

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
GLENMARK.NS 142.91%--239.11%26.28%
S&P 500 6.76%5.73%9.19%14.14%

Related Tickers